expresspharmaJanuary 28, 2021
Tag: Unichem , FDA , Zonisamide Capsules , ANDA
Unichem Laboratories has received ANDA approval for its Zonisamide Capsules, USP 25 mg, 50 mg and 100 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Zonegran (Zonisamide) Capsules of Sunovion Pharmaceuticals.
Zonisamide Capsules are indicated as adjunctive therapy in the treatment of partial seizures in adults with epilepsy. The product will be commercialised from Unichem’s Goa plant.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: